68 filings
8-K
BGLC
BioNexus Gene Lab Corp
18 Apr 24
Regulation FD Disclosure
1:44pm
10-K
2023 FY
BGLC
BioNexus Gene Lab Corp
Annual report
16 Apr 24
1:00pm
8-K
BGLC
BioNexus Gene Lab Corp
1 Apr 24
Departure of Directors or Certain Officers
3:59pm
NT 10-K
BGLC
BioNexus Gene Lab Corp
28 Mar 24
Notice of late annual filing
3:59pm
DEF 14C
ttppnr
29 Feb 24
Information statement
5:16pm
PRE 14C
0p6yl692
26 Jan 24
Preliminary information
4:05pm
NT 10-Q
ezq6x87k
14 Nov 23
Notice of late quarterly filing
11:54am
8-K
lgc8e b4k98dft
13 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
1:40pm
8-K
mb4ib
3 Nov 23
Departure of Directors or Certain Officers
10:55am
8-K/A
n2k58
30 Oct 23
Departure of Directors or Certain Officers
12:14pm
8-K
i99udptl7g54
16 Oct 23
Departure of Directors or Certain Officers
10:04am
8-K
bl977u2 5d6gsw6thr51
11 Oct 23
Departure of Directors or Certain Officers
10:02am
8-K
rfl 8x6100
7 Sep 23
Departure of Directors or Certain Officers
11:17am
NT 10-Q
1jfm8c2d7rva7wm0l
14 Aug 23
Notice of late quarterly filing
11:55am
8-K
cw4bc
24 Jul 23
BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:28pm
424B4
crs ohrtpa9hr
21 Jul 23
Prospectus supplement with pricing info
3:37pm
CERT
xlcy3z4 vxm
20 Jul 23
Certification of approval for exchange listing
12:28pm